Genmab Wraps Up Leveraged Finance’s Biggest M&A Deal Since April
Genmab A/S completed the US leveraged finance market’s largest acquisition funding since April, raising $4.5 billion through junk bonds and a leveraged loan.
By Kevin Kingsbury · Bloomberg Markets
Genmab A/S completed the US leveraged finance market’s largest acquisition funding since April, raising $4.5 billion through junk bonds and a leveraged loan.